Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARTH Arch Therapeutics		$0.12	$0.16 ▼ $1.57	$763K	4.02	4,068 shs	150 shs
ESMC Escalon Medical	$0.27 -12.9%	$0.33	$0.11 ▼ $0.46	$2M	0.43	2,063 shs	990 shs
GCTK GlucoTrack	$5.53 +1.5%	$6.20	$5.11 ▼ $3,756.00	$4.97M	-0.19	40,909 shs	16,819 shs
LGMK LogicMark	$0.00 -5.4%	$0.00	$0.00 ▼ $7.63	$2.02M	1.5	74.75 million shs	5.43 million shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARTH Arch Therapeutics	0.00%	0.00%	0.00%	+33.33%	-99.82%
ESMC Escalon Medical	0.00%	-30.77%	-21.45%	-22.86%	+129.59%
GCTK GlucoTrack	0.00%	-4.16%	-27.81%	-30.86%	-99.81%
LGMK LogicMark	0.00%	-18.60%	0.00%	-69.83%	-99.92%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ARTH Arch Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ESMC Escalon Medical	0.3122 of 5 stars	0.0	3.0	0.0	0.0	0.0	0.0	1.3
GCTK GlucoTrack	0.1925 of 5 stars	0.0	2.0	0.0	0.0	0.6	0.8	0.6
LGMK LogicMark	0.5225 of 5 stars	0.0	2.0	0.0	0.0	3.4	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARTH Arch Therapeutics	N/A	N/A	N/A
ESMC Escalon Medical	N/A	N/A	N/A
GCTK GlucoTrack	N/A	N/A	N/A
LGMK LogicMark	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARTH Arch Therapeutics	$80K	0.00	N/A	N/A	($2.43) per share	0.00
ESMC Escalon Medical	$11.98M	0.17	$0.04 per share	7.49	N/A	∞
GCTK GlucoTrack	N/A	N/A	N/A	N/A	$7.65 per share	N/A
LGMK LogicMark	$9.88M	0.20	N/A	N/A	$148.65 per share	0.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARTH Arch Therapeutics	-$6.98M	N/A	0.00	N/A	N/A	-8,257.70%	N/A	-730.22%	N/A
ESMC Escalon Medical	-$130K	$0.05	5.40	∞	N/A	4.70%	45.60%	12.66%	N/A
GCTK GlucoTrack	-$22.60M	-$56.60	N/A	∞	N/A	N/A	N/A	-352.05%	N/A
LGMK LogicMark	-$14.55M	-$223.50	N/A	∞	N/A	-141.96%	-124.91%	-92.05%	11/11/2025 (Estimated)

Latest ARTH, ESMC, GCTK, and LGMK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2025	Q2 2025	GCTK GlucoTrack	N/A	-$9.62	N/A	-$9.62	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARTH Arch Therapeutics	N/A	N/A	N/A	N/A	N/A
ESMC Escalon Medical	N/A	N/A	N/A	N/A	N/A
GCTK GlucoTrack	N/A	N/A	N/A	N/A	N/A
LGMK LogicMark	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARTH Arch Therapeutics	N/A	0.10	0.01
ESMC Escalon Medical	0.14	1.92	1.23
GCTK GlucoTrack	0.03	3.27	4.85
LGMK LogicMark	N/A	3.73	3.29

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ARTH Arch Therapeutics	6.91%
ESMC Escalon Medical	N/A
GCTK GlucoTrack	10.92%
LGMK LogicMark	7.88%

Insider Ownership

Company	Insider Ownership
ARTH Arch Therapeutics	4.50%
ESMC Escalon Medical	1.90%
GCTK GlucoTrack	12.91%
LGMK LogicMark	2.17%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ARTH Arch Therapeutics	10	4.74 million	4.53 million	Not Optionable
ESMC Escalon Medical	40	7.42 million	7.27 million	Not Optionable
GCTK GlucoTrack	5	900,000	783,000	Not Optionable
LGMK LogicMark	20	576.31 million	2.65 million	No Data

ARTH, ESMC, GCTK, and LGMK Headlines

Recent News About These Companies

LGMK: Device Upgrades Contribute to 2Q Revenue, Margin Improvements; Strong Balance Sheet, Sales Team Expanding

August 20, 2025 | msn.com

LogicMark Survey Reveals Women's Safety Concerns and Technology's Role in Personal Security

August 19, 2025 | quiverquant.comQ

Walking Alone at Night is the Greatest Safety Fear of Women Nationwide -- Almost Half Say Safety Concerns Limit Daily Activities LogicMark Poll Reveals

August 19, 2025 | globenewswire.com

LogicMark Reports 22% Revenue Increase in Q2 2025

August 14, 2025 | msn.com

LogicMark, Inc. (NASDAQ:LGMK) Q2 2025 Earnings Call Transcript

August 13, 2025 | insidermonkey.com

LogicMark, Inc. (LGMK) Q2 2025 Earnings Call Transcript

August 13, 2025 | seekingalpha.com

LogicMark, Inc. Reports Second Quarter 2025 Results Highlighted by 22% Sales Growth

August 12, 2025 | globenewswire.com

LogicMark, Inc. to Announce Q2 2025 Financial Results and Host Investor Call on August 12, 2025

July 29, 2025 | quiverquant.comQ

LogicMark's Holistic Approach: Leveraging Artificial Intelligence And SaaS To Protect Aging Loved Ones

June 4, 2025 | benzinga.com

LogicMark, Inc. Begins Trading on OTC Markets Following Nasdaq Delisting

June 2, 2025 | quiverquant.comQ

LogicMark, Inc. Common Stock to Commence Trading on OTC Markets as the Company Continues Advancing Growth Initiatives

June 2, 2025 | globenewswire.com

LogicMark to be delisted from Nasdaq

June 1, 2025 | uk.investing.com

LogicMark extends CEO’s contract, adjusts change control

May 22, 2025 | investing.com

LogicMark Extends CEO’s Term Amid Governance Changes

May 21, 2025 | tipranks.com

LogicMark reshuffles board, eyes tech-driven growth

April 29, 2025 | investing.com

These Seven Tiny Stocks Are Eating Up 72% Of Nasdaq Volume Today. Here Is The Fine Print.

April 29, 2025 | investors.com

LogicMark, Inc. Unveils New Board Committee Leadership Structure to Align with Strategic Goals

April 28, 2025 | globenewswire.com

LogicMark, Inc. (NASDAQ: $LGMK) Is Driving Growth Through AI-Powered Innovation!

April 24, 2025 | msn.com

LogicMark Stock Short Interest Report | NASDAQ:LGMK | Benzinga

April 19, 2025 | benzinga.com

LGMK: Potential Revenue Catalysts: GSA Approval, Medicaid Waivers, Device Upgrades

April 8, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ARTH, ESMC, GCTK, and LGMK Company Descriptions

Arch Therapeutics OTCMKTS:ARTH

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.

Escalon Medical OTCMKTS:ESMC

$0.27 -0.04 (-12.90%)

As of 08/22/2025 11:34 AM Eastern

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.

GlucoTrack NASDAQ:GCTK

$5.53 +0.08 (+1.47%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$5.52 -0.01 (-0.18%)

As of 08/22/2025 07:30 PM Eastern

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

LogicMark NASDAQ:LGMK

$0.0035 0.00 (-5.41%)

As of 08/22/2025 03:58 PM Eastern

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company's devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one's health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time